Clinical trial
A Phase 2A/2B, Dose-Finding and Expansion Study of Ad5.F35-hGCC-PADRE Vaccine in Adults With Gastrointestinal Adenocarcinomas at Risk of Relapse Post Definitive Surgery and Standard Therapy
NCT04111172 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2A/2B, Dose-Finding and Expansion Study of Ad5.F35-hGCC-PADRE Vaccine in Adults With Gastrointestinal Adenocarcinomas at Risk of Relapse Post Definitive Surgery and Standard Therapy
- Lead sponsor
- Thomas Jefferson University
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- November 10, 2020
- Completion date
- April 30, 2028
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clinical stage ii gastric cancer ajcc v8, clinical stage iia gastric cancer ajcc v8, clinical stage iib esophageal adenocarcinoma ajcc v8, clinical stage iib gastric cancer ajcc v8, clinical stage iii esophageal adenocarcinoma ajcc v8, clinical stage iii gastric cancer ajcc v8, colorectal adenocarcinoma, gastric adenocarcinoma, malignant digestive system neoplasm, malignant solid neoplasm, pancreatic ductal adenocarcinoma, pathologic stage ii gastric cancer ajcc v8, pathologic stage iib esophageal adenocarcinoma ajcc v8, pathologic stage iib gastric cancer ajcc v8, pathologic stage iii esophageal adenocarcinoma ajcc v8, pathologic stage iii gastric cancer ajcc v8, pathologic stage iiia esophageal adenocarcinoma ajcc v8, pathologic stage iiia gastric cancer ajcc v8, pathologic stage iiib esophageal adenocarcinoma ajcc v8, pathologic stage iiib gastric cancer ajcc v8, pathologic stage iiic gastric cancer ajcc v8, small intestinal adenocarcinoma, stage i pancreatic cancer ajcc v8, stage ia pancreatic cancer ajcc v8, stage ib pancreatic cancer ajcc v8, stage ii pancreatic cancer ajcc v8, stage iia pancreatic cancer ajcc v8, stage iib pancreatic cancer ajcc v8, stage iii colorectal cancer ajcc v8, stage iii pancreatic cancer ajcc v8, stage iii small intestinal adenocarcinoma ajcc v8, stage iiia colorectal cancer ajcc v8, stage iiia small intestinal adenocarcinoma ajcc v8, stage iiib colorectal cancer ajcc v8, stage iiic colorectal cancer ajcc v8, stage iv colorectal cancer ajcc v8, stage iva colorectal cancer ajcc v8, stage ivb colorectal cancer ajcc v8